z-logo
open-access-imgOpen Access
Cross‐linking gold nanoparticles aggregation method based on localised surface plasmon resonance for quantitative detection of miR‐155
Author(s) -
Esmaeilibandboni Aghil,
Amini Seyed Mohammad,
Faridimajidi Reza,
Bagheri Jamshid,
Mohammadnejad Javad,
Sadroddiny Esmaeil
Publication year - 2018
Publication title -
iet nanobiotechnology
Language(s) - English
Resource type - Journals
ISSN - 1751-875X
DOI - 10.1049/iet-nbt.2017.0174
Subject(s) - biosensor , detection limit , surface plasmon resonance , colloidal gold , materials science , analyte , nanoparticle , zeta potential , calibration curve , nanotechnology , analytical chemistry (journal) , chemistry , chromatography
MiR‐155 plays a critical role in the formation of cancers and other diseases. In this study, the authors aimed to design and fabricate a biosensor based on cross‐linking gold nanoparticles (AuNPs) aggregation for the detection and quantification of miR‐155. Also, they intended to compare this method with SYBR Green real‐time polymerase chain reaction (PCR). Primers for real‐time PCR, and two thiolated capture probes for biosensor, complementary with miR‐155, were designed. Citrate capped AuNPs (18.7 ± 3.6 nm) were synthesised and thiolated capture probes immobilised to AuNPs. The various concentrations of synthetic miR‐155 were measured by this biosensor and real‐time PCR method. Colorimetric changes were studied, and the calibration curves were plotted. Results showed the detection limit of 10 nM for the fabricated biosensor and real‐time PCR. Also, eye detection using colour showed the weaker detection limit (1 µM), for this biosensor. MiR‐133b as the non‐complementary target could not cause a change in both colour and UV–visible spectrum. The increase in hydrodynamic diameter and negative zeta potential of AuNPs after the addition of probes verified the biosensor accurately fabricated. This fabricated biosensor could detect miR‐155 simpler and faster than previous methods.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here